Nuevos marcadores de progresión de la enfermedad en mielofibrosis mdpi.com/2072-6694/13/2…

#MPNHZ21 MEET OUR SPEAKERS Day 1 MPN Horizons 2021 Virtual Conference

So excited to join this great meeting! The MPNAdvocatesNetwork continue to do an amazing job advancing advocacy for MPN patients around the world! Claire Harrison #HGisslinger #mpnsm @UTHealthSAMDA GUY'S MYELOID CENTRE J.J. Kiladjian Naveen Pemmaraju, MD

💊 NEWS | NICE recommends the use of fedratinib for treating disease-related splenomegaly or symptoms of #myelofibrosis in adults. They recommend that fedratinib should only be used after ruxolitinib.

I am a big fan of the new #EHA #ThinkingThursday series! 👇🏻👇🏻👇🏻

#ASH21 📅 11-14 Diciembre. 📣 Un programa lleno de sesiones científicas y esperamos que tengamos novedades en las NMP 🙏🤞🤞. Ensayos clínicos, nuevos inhibidores, combos, etc. Estaremos muy pendientes.

MPN Horizons 2021: Videos and presentations are now available for your review and download. 🎥 Read more about #MPNHZ21 and watch all videos of all sessions on demand🔽 mpn-advocates.net/mpn-horizons-v… #MPN #Conference #PatientAdvocacy

Ruxolitinib en pacientes con #mielofibrosis era seguro y bien tolerado, con tasas favorables de #GvHD, en un estudio piloto de fase I inicial ashpublications.org/bloodadvances/…

Marina Kremyanskaya presents oral abstract tomorrow: Pelabresib (CPI-0610) Monotherapy in Patients with Myelofibrosis – Update of Clinical and Translational Data from the Ongoing Manifest Trial ash.confex.com/ash/2021/webpr… #ASH21 Icahn School of Medicine at Mount Sinai

Improving lives for 21 years. The MPN Research Foundation. mpnresearchfoundation.org/impact/?fbclid…

ascopubs.org/doi/full/10.12…

If you missed our latest online event, it is now available to watch! We spoke with Ruben A. Mesa, MD and Naveen Pemmaraju, MD about clinical drugs and trials and what they all can do for MPN patients. Watch it now! youtu.be/Cu3HMwzaR_E

doi.org/10.1182/blooda…

Russian forces invaded Ukraine, a free and sovereign country. We condemn this barbaric attack, and the cynical arguments used to justify it. Later today we will present a package of massive, targeted sanctions. x.com/i/broadcasts/1…

The day that history changed in Europe.

While #MPNs are often associated with near-normal life expectancies when appropriately treated, it can still be overwhelming to receive a diagnosis. Everyone has a different experience, but these 10 tips can help you cope with your #MPN diagnosis: bit.ly/3BPr396

"Adjetivos como grato y divertido sustituyen el conocimiento del bien y del mal. Todo debe ser inmediato, nuevo, rápido. Como nadie tiene el monopolio del saber, todo el mundo tiene razón. Y como todos somos iguales, lo difícil es antidemocrático". (Riemen. Nobleza de espíritu)

#ASH22| Bridget Marcellino Icahn School of Medicine at Mount Sinai discusses dual targeting of HDM2 and PPM1D as a novel approach for MF. She highlights that PPM1D inhibitors sensitises MF HSPCs to an HDM2 inhibitor and that a novel PPM1D targeting agent is in development #MPN #MPNsm #medicalcongress

#ASH22 | Rosa Ayala Medicina Interna Hospital 12 de Octubre presents BETi BMS-986158 + RUX/FED is reported to have acceptable and manageable safety profiles. BMS-986158 + RUX produced early and deep spleen volume reduction. Enrollment ongoing for RP2D. #medicalcongress #MPN #MPNsm @ASH22

An antibody for myelofibrosis – “that’s a true discovery” - Leukaemia Foundation leukaemia.org.au/stories/an-ant…